Cargando…
Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087923/ https://www.ncbi.nlm.nih.gov/pubmed/27784842 http://dx.doi.org/10.5009/gnl16476 |
| _version_ | 1782463996287254528 |
|---|---|
| author | Kim, Hwi Young |
| author_facet | Kim, Hwi Young |
| author_sort | Kim, Hwi Young |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5087923 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50879232016-11-02 Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! Kim, Hwi Young Gut Liver Editorial Editorial Office of Gut and Liver 2016-11 2016-11-15 /pmc/articles/PMC5087923/ /pubmed/27784842 http://dx.doi.org/10.5009/gnl16476 Text en Copyright © 2016 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Kim, Hwi Young Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! |
| title | Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! |
| title_full | Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! |
| title_fullStr | Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! |
| title_full_unstemmed | Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! |
| title_short | Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders! |
| title_sort | comparative effectiveness of lamivudine versus entecavir in patients with hepatocellular carcinoma: watch out for confounders! |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087923/ https://www.ncbi.nlm.nih.gov/pubmed/27784842 http://dx.doi.org/10.5009/gnl16476 |
| work_keys_str_mv | AT kimhwiyoung comparativeeffectivenessoflamivudineversusentecavirinpatientswithhepatocellularcarcinomawatchoutforconfounders |